Search

Author/Creator Marker, Mahtab

1. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study. Issue 3 (March 2021)

Authors:
Syeda, Mahrukh M; Wiggins, Jennifer M; Corless, Broderick C; Long, Georgina V; Flaherty, Keith T; Schadendorf, Dirk; Nathan, Paul D; Robert, Caroline; Ribas, Antoni; Davies, Michael A; Grob, Jean Jacques; Gasal, Eduard; Squires, Matthew; Marker, Mahtab; Garrett, James; Brase, Jan C; Polsky, David
Journal:
Lancet oncology
Issue:
Volume 22:Issue 3(2021)
Page Start:
370
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study. Issue 12 (December 2018)

Authors:
Voss, Martin H; Reising, Albert; Cheng, Yuan; Patel, Parul; Marker, Mahtab; Kuo, Fengshen; Chan, Timothy A; Choueiri, Toni K; Hsieh, James J; Hakimi, A Ari; Motzer, Robert J
Journal:
Lancet oncology
Issue:
Volume 19:Issue 12(2018)
Page Start:
1688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search